Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The evolving role of investigative toxicology in the pharmaceutical industry
François Pognan, Mario Beilmann, Harrie C. M. Boonen, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 4, pp. 317-335
Open Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

Drug discovery and development: introduction to the general public and patient groups
Natesh Singh, Philippe Vayer, Shivalika Tanwar, et al.
Frontiers in Drug Discovery (2023) Vol. 3
Open Access | Times Cited: 70
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 66
TheMarker: a comprehensive database of therapeutic biomarkers
Yintao Zhang, Ying Zhou, Yuan Zhou, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1450-D1464
Open Access | Times Cited: 37
Bioactive limonoids from Carapa guianensis seeds oil and the sustainable use of its by-products
Vagner Pereira da Silva, Lavínia de Carvalho Brito, André Mesquita Marques, et al.
Current Research in Toxicology (2023) Vol. 4, pp. 100104-100104
Open Access | Times Cited: 25
A Review on the Recent Applications of Deep Learning in Predictive Drug Toxicological Studies
Krishnendu Sinha, Nabanita Ghosh, Parames C. Sil
Chemical Research in Toxicology (2023) Vol. 36, Iss. 8, pp. 1174-1205
Closed Access | Times Cited: 22
Capture of the Mouse Organ Membrane Proteome Specificity in Peptidisc Libraries
Frank Antony, Zora Brough, Zhiyu Zhao, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 2, pp. 857-867
Closed Access | Times Cited: 10
Cell Membrane‐Coated Nanoparticles: A New Frontier in Immunomodulation
Nimeet Desai, Vishakha Tambe, Prasad Pofali, et al.
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 8
Open Access | Times Cited: 9
Clinical translation of nanomedicine with integrated digital medicine and machine learning interventions
Farooq Ahmad, Tahir Muhmood
Colloids and Surfaces B Biointerfaces (2024) Vol. 241, pp. 114041-114041
Closed Access | Times Cited: 8
The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges
Chiranjib Chakraborty, Manojit Bhattacharya, Sang‐Soo Lee, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102295-102295
Open Access | Times Cited: 8
D-peptide hydrogels as a long-acting multipurpose drug delivery platform for combined contraception and HIV prevention
Sreekanth Pentlavalli, Sophie Coulter, Yuming An, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 30-44
Open Access | Times Cited: 1
Machine Learning‐Enabled Drug‐Induced Toxicity Prediction
Changsen Bai, Lianlian Wu, Ruijiang Li, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Evolution and impact of high content imaging
Gregory P. Way, Heba Sailem, Steven Shave, et al.
SLAS DISCOVERY (2023) Vol. 28, Iss. 7, pp. 292-305
Open Access | Times Cited: 21
Emerging Technologies and Advanced Biomarkers for Enhanced Toxicity Prediction and Safety Pharmacology
Tamer A. Addissouky
Advances in Clinical Toxicology (2024) Vol. 9, Iss. 1, pp. 1-9
Open Access | Times Cited: 6
Transforming Toxicity Assessment through Microphysiology, Bioprinting, and Computational Modeling
Tamer A. Addissouky
Advances in Clinical Toxicology (2024) Vol. 9, Iss. 1, pp. 1-14
Open Access | Times Cited: 6
In vitro immunity: an overview of immunocompetent organ-on-chip models
Andrew I. Morrison, Mirthe J. Sjoerds, Leander A. Vonk, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Progress in toxicogenomics to protect human health
Matthew J. Meier, Joshua Harrill, Kamin J. Johnson, et al.
Nature Reviews Genetics (2024)
Closed Access | Times Cited: 6
DrugMAP 2.0: molecular atlas and pharma-information of all drugs
Fengcheng Li, Minjie Mou, LI Xiao-yi, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1372-D1382
Open Access | Times Cited: 6
Phytoconstituent-Loaded Nanofibrous Meshes as Wound Dressings: A Concise Review
Ameya Sharma, Divya Dheer, Inderbir Singh, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1058-1058
Open Access | Times Cited: 14
Stability-based approaches in chemoproteomics
Amy L. George, María Emilia Dueñas, José Luis Marín‐Rubio, et al.
Expert Reviews in Molecular Medicine (2024) Vol. 26
Open Access | Times Cited: 5
A deep learning based multi-model approach for predicting drug-like chemical compound’s toxicity
Konda Mani Saravanan, Jiang-Fan Wan, Liujiang Dai, et al.
Methods (2024) Vol. 226, pp. 164-175
Closed Access | Times Cited: 5
Nanomaterial-Driven Precision Immunomodulation: A New Paradigm in Therapeutic Interventions
Alaa A. A. Aljabali, Mohammad A. Obeid, Omar Gammoh, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2030-2030
Open Access | Times Cited: 5
Roadblocks confronting widespread dissemination and deployment of Organs on Chips
Charles G. Alver, Emma Drabbe, Matthew Ishahak, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Endeavours made by trade associations, pharmaceutical companies and regulators in the replacement, reduction and refinement of animal experimentation in safety testing of pharmaceuticals.
Andrew W. Harrell, Kirsty Reid, John L. Vahle, et al.
Regulatory Toxicology and Pharmacology (2024) Vol. 152, pp. 105683-105683
Open Access | Times Cited: 5
Emerging biophysical techniques for probing synaptic transmission in neurodegenerative disorders
Mayur B. Kale, Nitu L. Wankhede, Ashok Kumar Bishoyi, et al.
Neuroscience (2024) Vol. 565, pp. 63-79
Closed Access | Times Cited: 4
Therapeutic Efficacy Studies on the Monoterpenoid Hinokitiol in the Treatment of Different Types of Cancer
Md. Shimul Bhuia, Raihan Chowdhury, Meher Afroz, et al.
Chemistry & Biodiversity (2025)
Closed Access
Page 1 - Next Page

Scroll to top